Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Delcath Systems (NASDAQ: DCTH) is Profiled in this Database

Updated At 02 Oct, 2016

Start Free 7 Day Trial Now
Partial description of this company
High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Delcath Systems (NASDAQ: DCTH) plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About Delcath Systems (NASDAQ: DCTH)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Our Clients